Gene-edited cows, rogue clinics, speedier drug approvals: the challenges facing Trump's FDA chief

Heidi Ledford

Nature, 2017, vol. 541, issue 7636, 146-147

Abstract: The agency's next leader will have an opportunity to reshape its approach to regulation.

Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/nature.2017.21256 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:541:y:2017:i:7636:d:10.1038_nature.2017.21256

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature.2017.21256

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().